Literature DB >> 14614667

Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.

M Melzer1, S J Eykyn, W R Gransden, S Chinn.   

Abstract

Staphylococcus aureus is the most common cause of hospital-acquired bacteremia. From 1995 through 2000, data on age, sex, patient specialty at time of first bacteremia, primary and secondary sites of infection, delay in initiating antimicrobial therapy, and patient outcome were prospectively recorded for 815 patients with nosocomial S. aureus bacteremia. The proportion of patients whose death was attributable to methicillin-resistant S. aureus (MRSA) was significantly higher than that for methicillin-susceptible S. aureus (MSSA) (11.8% vs. 5.1%; odds ratio [OR], 2.49; 95% confidence interval [CI], 1.46-4.24; P<.001). After adjustment for host variables, the OR decreased to 1.72 (95% CI, 0.92-3.20; P=.09). There was no significant difference between rates of disseminated infection (7.1% vs. 6.2% for MRSA-infected patients and MSSA-infected patients, respectively; P=.63), though the rate of death due to disseminated infection was significantly higher than death due to uncomplicated infection (37% vs. 10% for MRSA-infected patients [P<.001] and 37% vs. 3% for MSSA-infected patients [P<.001]). There was a strong statistical trend toward death due to nosocomial MRSA infection and bacteremia, compared with MSSA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614667     DOI: 10.1086/379321

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  48 in total

1.  Linezolid in VAP by MRSA: a better choice?

Authors:  Malina Ioanas; Hartmut Lode
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

2.  Safety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trial.

Authors:  Alexander Konychev; Markus Heep; Rose K C Moritz; Alexander Kreuter; Alexander Shulutko; Gerhard Fierlbeck; Kamel Bouylout; Rashidkhan Pathan; Uwe Trostmann; Ricardo L Chaves
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

3.  Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals.

Authors:  R A Seaton; S Johal; J E Coia; N Reid; S Cooper; B L Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-31       Impact factor: 3.267

4.  Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital.

Authors:  Hwa Yun Cha; Dong Chan Moon; Chul Hee Choi; Jae Young Oh; Young Sook Jeong; Yoo Chul Lee; Sung Yong Seol; Dong Taek Cho; Hyun-Ha Chang; Shin-Woo Kim; Je Chul Lee
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.

Authors:  David H Wyllie; Derrick W Crook; Tim E A Peto
Journal:  BMJ       Date:  2006-06-23

Review 6.  MRSA - 'bug-bear' of a surgical practice: reducing the incidence of MRSA surgical site infections.

Authors:  Andrea Guyot; Graham Layer
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

7.  Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection.

Authors:  Kazue Takahashi; Lei Shi; Lakshmi D Gowda; R Alan B Ezekowitz
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia.

Authors:  James Price; Gillian Baker; Ian Heath; Karen Walker-Bone; Marc Cubbon; Sally Curtis; Mark C Enright; Jodi Lindsay; John Paul; Martin Llewelyn
Journal:  Int J Microbiol       Date:  2010-03-16

9.  Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.

Authors:  Poonam Sood Loomba; Juhi Taneja; Bibhabati Mishra
Journal:  J Glob Infect Dis       Date:  2010-09

10.  Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study.

Authors:  Deverick J Anderson; Keith S Kaye; Luke F Chen; Kenneth E Schmader; Yong Choi; Richard Sloane; Daniel J Sexton
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.